Brief: Tevogen Announces Reverse Stock Split
Brief: Tevogen Signs LOI To Evaluate Potential Acquisition Of Sciometrix
U.S. STOCKS ON THE MOVE-Enovis, Cheniere, Packaging Corp of America
Tevogen rises on plans to buy majority stake in digital health firm Sciometrix
Brief: Tevogen Says Actively Preparing For Next Stage Of Development Of TVGN 489
Brief: Tevogen Values TVGN-489 at $9–$11B, Debuts First Clinical T Cell Therapy from ExacTcell™ Platform
Brief: Tevogen Bio Holdings Anticipates Revenue By End Of 2026
Brief: Tevogen Bio Sees $1 Bln Revenue In Launch Year For Oncology
Brief: Tevogen Receives $1 Million To Accelerate AI-Driven Drug Discovery
Brief: Tevogen.AI Expands Collaboration With Databricks And Microsoft
Brief: Tevogen Bio Holdings Enters $50 Million Sales Agreement With Alliance Global Partners
Brief: Tevogen Bio Holdings files for mixed shelf of up to $150 mln – SEC filing
Brief: Tevogen CEO To Join Dialogue On Paths To Liquidity at BioNJ’s Fifteenth Annual Bio Partnering Conference
Tevogen gains after it reaffirms revenue forecast for experimental oncology drugs
Brief: Tevogen Bio Announces Unique T Cell Vaccine Under Development & Files Patent With USPTO
Brief: Tevogen Bio To Receive $8 Mln Of Non-Dilutive Grant Funding
U.S. STOCKS ON THE MOVE-Middleby, Boeing, Aurora Mobile
U.S. STOCKS ON THE MOVE-Sagimet Biosciences, Sage Therapeutics, Qorvo
U.S. STOCKS ON THE MOVE-Tevogen Bio, Akero Therapeutics, AspenTech